EUVIMEDEUVIMED entdecken
Crossref

Comparison of Efficacy and Safety of Latanoprost versus Fixed Combination of Tafluprost and Timolol in Patients with Primary Open-Angle Glaucoma

International Journal of Biomedicine · 10.12.2024 · 14 (4) · 621-625

DOI: 10.21103/article14(4)_oa14 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biomedicine, online erschienen am 05.12.2024.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Glaucoma is a progressive disease that requires lifelong treatment to maintain visual function. Elevated intraocular pressure (IOP) is considered the most important treatable risk factor for disease development and progression. The present prospective study was initiated to compare the IOP lowering efficacy and safety of the preservative-free (PF) fixed combination of 0.0015% tafluprost and 0.5% timolol maleate (FCTT) administered once daily versus 0.005% latanoprost (LT) once daily. Materials and Methods: One hundred newly diagnosed patients with primary open-angle glaucoma (POAG) who fulfilled the inclusion/exclusion criteria were enrolled and randomized into two groups. The first LP group was prescribed 0.005% latanoprost eye drops once daily, whereas the second FCTT group was prescribed a PF fixed combination of 0.0015% tafluprost and 0.5% timolol once daily. In both groups, IOP was recorded at baseline, at the end of the fourth, eighth, and twelfth weeks, and six months after, and any adverse effects were assessed. The primary efficacy endpoint, absolute mean IOP reduction six months after LP or FCTT treatment from baseline IOP, was statistically significant for both treatment groups (P

Zitieren

APA

(2024). Comparison of Efficacy and Safety of Latanoprost versus Fixed Combination of Tafluprost and Timolol in Patients with Primary Open-Angle Glaucoma. International Journal of Biomedicine, 14(4), 621-625. https://doi.org/10.21103/article14(4)_oa14

Vancouver

Comparison of Efficacy and Safety of Latanoprost versus Fixed Combination of Tafluprost and Timolol in Patients with Primary Open-Angle Glaucoma. International Journal of Biomedicine. 2024;14(4):621-625. doi:10.21103/article14(4)_oa14

BibTeX
@article{euvimed2024,
  title = {Comparison of Efficacy and Safety of Latanoprost versus Fixed Combination of Tafluprost and Timolol in Patients with Primary Open-Angle Glaucoma},
  journal = {International Journal of Biomedicine},
  year = {2024},
  volume = {14},
  number = {4},
  pages = {621--625},
  doi = {10.21103/article14(4)_oa14}
}
Kostenlos starten →